Actively Recruiting
PhillyCEAL: Addressing Disparities in Chronic Disease Self-management Through an Enhanced Community Health Worker Program
Led by University of Pennsylvania · Updated on 2025-10-01
500
Participants Needed
1
Research Sites
15 weeks
Total Duration
On this page
Sponsors
U
University of Pennsylvania
Lead Sponsor
W
Westat
Collaborating Sponsor
AI-Summary
What this Trial Is About
Cardiovascular disease (CVD) affects racial and ethnic minority groups and underserved populations in Philadelphia more than others. This research evaluates an enhanced community health worker (CHW) program combining the DECIDE self-management intervention with structured CHW consultations. The goal is to improve CVD self-management skills and address social needs among 500 Philadelphia residents aged 35 to 75 who have CVD risk factors and unmet social needs. The study uses a Type 1 Hybrid Effectiveness-Implementation Design to compare outcomes and understand factors influencing participation and CHW experiences. Participants are randomly assigned to receive either the DECIDE+ intervention or continue with standard CHW services. The DECIDE program consists of nine bi-weekly group sessions focused on education and problem-solving to support behavior changes for better chronic disease management. Those in the DECIDE+ group also receive CHW follow-up calls either biweekly or monthly. The standard care group receives CHW services and follow-up calls on a biweekly or monthly schedule without the DECIDE sessions. Community advisory council support helps mobilize resources to address social needs. During the study, participants will be assessed on their CVD self-management skills using the Self-care of Chronic Illness Inventory Maintenance scale over six months. Researchers will also track changes in health behaviors and the resolution of social needs. Implementation outcomes include CHW knowledge, attitudes, job satisfaction, and the impact of community advisory council efforts. The study aims to provide evidence on combining self-management programs with CHW services to reduce health disparities and improve cardiovascular health outcomes.
CONDITIONS
Brief Title
Philly CEAL- DECIDE+ Adaptation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Reside in Philadelphia
- Be between 35 and 75 years of age (inclusive)
- Self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions: pre-diabetes, diabetes, hypertension, high cholesterol, or BMI of 30 or higher
- Have completed an initial visit with a CEO community health worker
- Have one or more unmet social needs in areas such as housing stability, food security, transportation, employment, household utilities, healthcare access, health literacy, or social support
- Willing to consent to participate in the study and have regular access to a mobile device
You will not qualify if you...
- Do not reside in Philadelphia
- Not between 35 and 75 years of age (inclusive)
- Do not self-report having one or more of the specified CVD-related chronic conditions
- Have not completed an initial visit with a CEO community health worker
- Do not have any unmet social needs in the specified areas
- Unwilling to consent to participate or lack regular access to a mobile device
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 6 months
Participants engage in the DECIDE group-based self-management program facilitated by community health workers, focusing on cardiovascular disease problem solving and self-management skills. Participants also receive community health worker support through follow-up calls to address social needs and support behavior change.
Biweekly or monthly follow-up calls depending on assigned intervention arm, plus group session visits every two weeks for 9 sessions
Trial Site Locations
Total: 1 location
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
J
Jose Bauermeister, MPH, PhD
G
Gladys Thomas, MBA
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here